<DOC>
	<DOCNO>NCT00977301</DOCNO>
	<brief_summary>The effect fosamprenavir/ritonavir ( steady state ) pharmacokinetics single dose olanzapine study . In study , investigator expect inducible effect fosamprenavir/ritonavir CYP1A2 UGT metabolism olanzapine .</brief_summary>
	<brief_title>Interaction Between Fosamprenavir/Ritonavir Single-dose Olanzapine ( FORZA )</brief_title>
	<detailed_description>Psychosis mental illness commonly describe patient infected human immunodeficiency virus ( HIV ) . New-onset psychosis estimate occur 15 % patient infect HIV 5 7 % patient HIV-infection suffer pre-existing mental illness include schizophrenia . Olanzapine could attractive antipsychotic HIV/AIDS patient schizophrenia . Because olanzapine substrate UGT CYP1A2 , pharmacokinetics olanzapine might influence low-dose ritonavir combination fosamprenavir . The current study design test hypothesis . Furthermore , study evaluate safety combination .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Fosamprenavir</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Subject least 18 old 55 year screen . Subject Quetelet Index ( Body Mass Index ) 18 30 kg/m2 , extremes include . Subject able willing sign Informed Consent Form prior screen evaluation . Subject good ageappropriate health condition establish medical history , physical examination , electrocardiography , result biochemistry , haematology urinalysis test within 4 week prior first dose . Results biochemistry , haematology urinalysis test within laboratory 's reference range . If laboratory result within reference range , subject include condition Investigator judge deviation clinically relevant . This clearly record . Subject normal blood pressure pulse rate , accord Investigator 's judgement . Documented history sensitivity/idiosyncrasy medicinal product excipients . Positive HIV test . Positive hepatitis B C test . Pregnant female ( confirm HCG test perform less 4 week first dose ) breastfeed female . Female subject childbearing potential without adequate contraception , e.g . hysterectomy , bilateral tubal ligation , ( nonhormonal ) intrauterine device , total abstinence , double barrier method , two year postmenopausal . They must agree take precaution order prevent pregnancy throughout entire conduct trial . Therapy drug ( two week precede dose ) , except paracetamol . Relevant history presence pulmonary disorder ( especially COPD ) , cardiovascular disorder , neurological disorder ( especially seizures migraine ) , psychiatric disorder , glaucoma , gastrointestinal disorder , renal hepatic disorder , hormonal disorder ( especially diabetes mellitus ) , coagulation disorder . Relevant history current condition might interfere drug absorption , distribution , metabolism excretion . History current abuse drug , alcohol solvent . Inability understand nature extent trial procedure require . Participation drug trial within 60 day prior first dose . Donation blood within 60 day prior first dose . Febrile illness within 3 day first dose . History narrowangle glaucoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>interaction</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>